检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘亮[1] 左静[2] 赵丽[1] 王静[1] 郭建文[1] 刘江惠[1] 左连富[1]
机构地区:[1]河北医科大学第四医院肿瘤研究所流式细胞室,石家庄050011 [2]河北医科大学第四医院肿瘤内科,石家庄050011
出 处:《中国医科大学学报》2010年第2期101-104,共4页Journal of China Medical University
基 金:河北省普通高等学校强势特色学科-肿瘤学建设经费资助项目(冀教高[2005]52号);河北省自然科学基金资助项目(C2007001060)
摘 要:目的研究阿霉素(ADM)药物诱导食管癌细胞(Eca109)产生耐药细胞株(Eca109/ADM)中ATP结合转运蛋白G超家族成员2(ABCG2)的表达及其意义。方法通过逐步增加培养液中阿霉素的浓度,长期筛选培养,建立食管癌耐药细胞株Eca109/ADM。逆转录聚合酶链反应(RT-PCR)方法检测耐药细胞中ABCG2mRNA的表达量,流式细胞术(FCM)和蛋白印迹(Westernblot)方法检测耐药细胞中ABCG2蛋白的表达量及细胞定位。FCM方法检测Eca109/ADM细胞药物外排作用,MTT方法检测Eca109/ADM细胞对阿霉素的耐药系数。结果Eca109/ADM细胞与Eca109细胞相比,ABCG2表达显著性增高(P<0.05)。Eca109/ADM细胞药物外排作用较Eca109细胞增加,Eca109/ADM细胞对阿霉素的耐药系数为3.29。结论成功建立耐药细胞株Eca109/ADM。Eca109/ADM细胞是一个理想的耐药细胞模型。Eca109/ADM细胞中ABCG2的表达量增高,提示ABCG2参与食管癌细胞耐药的形成。Objective To explore the expression of ATP-binding cassette transporter G2 (ABCG2) in adriamycin (ADM)-resistant human esophageal cancer cells. Melhods The ADM-resistant human esophageal cancer cell (Ecal09/ADM) was induced by gradually increasing the ADM concentration in the culture medium of human esophageal cancer cell line(Ecal09) and long time screening culture. ABCG2 mRNA and protein of ADM-resistant cells was detected by RT-PCR,flow cytometry (FCM) and Westem blot. Drug excretion of Ecal09/ADM cells was examined by FCM. The drug resistance index to ADM was detected by MTT. Results The expression of ABCG2 in Eca109/ADM cells was higher than that in Ecal09 cells. The drug excretion of Ecal09/ADM cells was stronger than Eca109 cells. The Eca109/ADM cells drug resistance index to ADM was 3.29. Conclusion The ADM-resistant cell line Eca109/ADM was established successfully as an ideal chemoresistant cell model. ABCG2 might be involved in the drug resistance of esophageal cancer cell.
关 键 词:ATP结合转运蛋白G超家族成员2 流式细胞术 阿霉素 食管癌
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249